IL-6 and hsCRP in Somatic Symptom Disorders and related disorders

Aaronson, 1998, Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations, J. Clin. Epidemiol., 51, 1055, 10.1016/S0895-4356(98)00097-3 Allen, 2020, The associations between loneliness, social exclusion and pain in the general population: a N=502,528 cross-sectional UK Biobank study, J. Psychiatr. Res., 130, 68, 10.1016/j.jpsychires.2020.06.028 2013 Anda, 1998 Andrés-Rodríguez, 2019, Peripheral immune aberrations in fibromyalgia: a systematic review, meta-analysis and meta-regression, Brain Behav. Immun., S0889–1591, 31274 Andrés-RodríguezL, 2019, Machine learning to understand the immune-inflammatory pathways in fibromyalgia, Int. J. Mol. Sci., 20, E4231, 10.3390/ijms20174231 Atzeni, 2019, Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab, Pharmacol. Res., 149, 104402, 10.1016/j.phrs.2019.104402 Baumeister, 2016, Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α, Mol. Psychiatr., 21, 642-649, 10.1038/mp.2015.67 Brecht, 2007, Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial, J. Clin. Psychiatr., 68, 1707, 10.4088/JCP.v68n1110 Cho, 2013, Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study, Psychological Medicine Care, 43, 1773, 10.1017/S0033291712002437 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297 De Waal, 2004, Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders, Br. J. Psychiatry, 184, 470, 10.1192/bjp.184.6.470 Del Grande da Silva, 2016, Pro-inflammatory cytokines and psychotherapy in depression: results from a randomized clinical trial, J. Psychiatr. Res., 75, 57, 10.1016/j.jpsychires.2016.01.008 Desai, 2002, Childhood victimization and subsequent adult revictimization assessed in a nationally representative sample of women and men, Violence Vict., 17, 639, 10.1891/vivi.17.6.639.33725 Dowlati, 2010, A meta- analysis of cytokines in major depression, Biol. Psychiatr., 67, 446, 10.1016/j.biopsych.2009.09.033 Einvik, 2012, Circulating cytokine concentrations are not associated with major depressive disorder in a community-based cohort, Gen. Hosp. Psychiatr., 34, 262, 10.1016/j.genhosppsych.2012.01.017 Gabay, 2006, Interleukin-6 and chronic inflammation, Arthritis Res. Ther., 8, S3, 10.1186/ar1917 Gaines Das, 1993, The international standard for interleukin-6. Evaluation in an international collaborative study, J. Immunol. Methods, 160, 147, 10.1016/0022-1759(93)90172-4 Garratt, 1994, SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions, Qual. Health C are, 3, 186, 10.1136/qshc.3.4.186 Garvin, 2016, The joint subclinical elevation of CRP and IL-6 is associated with lower health-related quality of life in comparison with no elevation or elevation of only one of the biomarkers, Qual. Life Res., 25, 213, 10.1007/s11136-015-1068-6 Gouin, 2017, Resilience resources moderate the association of adverse childhood experiences with adulthood inflammation, Ann. Behav. Med., 51, 782, 10.1007/s12160-017-9891-3 Grosse, 2016, Cytokine levels in major depression are related to childhood trauma but not to recent stressors, Psychoneuroendocrinology, 73, 24, 10.1016/j.psyneuen.2016.07.205 Haack, 2007, Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers, Sleep, 30, 1145, 10.1093/sleep/30.9.1145 Harris, 1999, Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly, Am. J. Med., 106, 506-512, 10.1016/S0002-9343(99)00066-2 Holmes, 1967, The social readjustment rating scale, J. Psychosom. Res., 11, 213, 10.1016/0022-3999(67)90010-4 Howren, 2009, Associations of depression with Creactive protein, IL-1, and IL-6: a meta-analysis, Psychosom. Med., 71, 171, 10.1097/PSY.0b013e3181907c1b Huyse, 1999, INTERMED": a method to assess health service needs. I. Development and reliability, Gen. Hosp. Psychiatr., 21, 39, 10.1016/S0163-8343(98)00057-7 Koenig, 1999, C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men, Circulation, 99, 237, 10.1161/01.CIR.99.2.237 Kovacs, 2016, Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes, J. Neural. Transm., 123, 541, 10.1007/s00702-016-1506-9 Kroenke, 2002, The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms, Psychosom. Med., 64, 258, 10.1097/00006842-200203000-00008 Kroenke, 2009, The PHQ-8 as a measure of current depression in the general population, J. Affect. Disord., 114, 163, 10.1016/j.jad.2008.06.026 Kroenke, 2010, The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review, Gen. Hosp. Psychiatr., 32, 345, 10.1016/j.genhosppsych.2010.03.006 Lemieux A, 2008, Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment, Brain Behav. Immun., 22, 994, 10.1016/j.bbi.2008.02.005 Lindqvist, 2017, Increased pro-inflammatory milieu in combat related PTSD - a new cohort replication study, Brain Behav. Immun., 59, 260, 10.1016/j.bbi.2016.09.012 Luna, 2014, High-sensitivity C-reactive protein and interleukin-6–dominant inflammation and ischemic stroke risk. The northern manhattan study, Stroke, 45, 979, 10.1161/STROKEAHA.113.002289 Mayo Clinic, 2020 McHorney, 1993, The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs, Med. Care, 13, 247, 10.1097/00005650-199303000-00006 Mendieta, 2016, IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients, J. Neuroimmunol., 290, 22-25, 10.1016/j.jneuroim.2015.11.011 Miller, 2003, Pathways linking depression, adiposity, and inflammatory markers in healthy young adults, Brain Behav. Immun., 17, 276, 10.1016/S0889-1591(03)00057-6 Pasco, 2010, Association of high-sensitivity C-reactive protein with de novo major depression, Br. J. Psychiatr., 197, 372, 10.1192/bjp.bp.109.076430 Pearson, 2003, Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: a statement for healthcare professionals from the Centers for disease control and prevention and the American heart association, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 Pedrotti Moreira, 2018, Childhood trauma and increased peripheral cytokines in young adults with major depressive disorder: population-based study, J. Neuroimmunol., 15, 112, 10.1016/j.jneuroim.2018.02.018 Pfützner, 2006, High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Review, Diab. Technol. Therap., 8, 28, 10.1089/dia.2006.8.28 Powers, 2019, The differential effects of PTSD, MDD, and dissociation on CRP in trauma-exposed women, Compr. Psychiatr., 93, 33, 10.1016/j.comppsych.2019.06.007 Quartana, 2015, Effects of insomnia disorder and knee osteoarthritis on resting and pain-evoked inflammatory markers, Brain Behav. Immun., 228, 10.1016/j.bbi.2014.12.010 Ridker, 2016, From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Review, Circ. Res., 8, 145, 10.1161/CIRCRESAHA.115.306656 Rief, 2010, Overnight changes of immune parameters and catecholamines are associated with mood and stress, Psychosom. Med., 72, 755, 10.1097/PSY.0b013e3181f367e2 Scheller, 2011, The pro- and anti-inflammatory properties of the cytokine interleukin-6, Biochim. Biophys. Acta, 1813, 878, 10.1016/j.bbamcr.2011.01.034 Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J. Clin. Psychiatr., 22 Simon, 2008, A detailed examination of cytokine abnormalities in major depressive disorder, Eur. Neuropsychopharmacol, 18, 230, 10.1016/j.euroneuro.2007.06.004 Spitzer, 1990 Spitzer, 2006, A brief measure for assessing generalized anxiety disorder: the GAD-7, Arch. Intern. Med., 166, 1092, 10.1001/archinte.166.10.1092 Tan, 2004, Validation of the brief pain inventory for chronic nonmalignant pain, J. Pain, 5, 133 Tanaka, 2014, IL-6 in inflammation, immunity, and disease, Cold Spring Harbor Perspect. Biol., 6, 10.1101/cshperspect.a016295 Tsalik, 2012, Discriminative value of inflammatory biomarkers for suspected sepsis, J. Emerg. Med., 43, 97, 10.1016/j.jemermed.2011.05.072 Uçeyler, 2011, Systematic review with meta-analysis: cytokines in fibromyalgia syndrome, BMC Muscoskel. Disord., 12, 245, 10.1186/1471-2474-12-245 van der Feltz-Cornelis, 2020, Diagnostic profiling in clinical translational research — a European perspective, Eur. J. Psychiatr., 34, 57, 10.1016/j.ejpsy.2019.11.003 van der Feltz-Cornelis, 2019, Adverse Childhood Experiences (ACE) in outpatients with anxiety and depressive disorders and their association with psychiatric and somatic comorbidity and revictimization. Cross-sectional observational study, J. Affect. Disord., 246, 458, 10.1016/j.jad.2018.12.096 Van Eck van der Sluijs, 2017, Complexity assessed by the intermed in patients with somatic symptom disorder visiting a specialized outpatient mental health care setting: a cross-sectional study, Psychosomatics, 58, 427, 10.1016/j.psym.2017.02.008 Van Hemert, 2003 Viljoen, 2005, Non-termination of sickness behavior as precipitating factor for mental disorders, Med. Hypotheses, 65, 316, 10.1016/j.mehy.2004.08.032 Vogelzangs, 2016, Cytokine production capacity in depression and anxiety, Transl. Psychiatry, 6, e825, 10.1038/tp.2016.92 Volanakis, 2001, Human C-reactive protein: expression,structure, and function, Mol. Immunol., 38, 189, 10.1016/S0161-5890(01)00042-6 Ware, 1992, The MOS 36-item short-form health survey (SF-36), Med. Care, 30, 473, 10.1097/00005650-199206000-00002 Ware, 1994 Werner, 2016, The association between childhood maltreatment, psychopathology, and adult sexual victimization in men and women: results from three independent samples, Psychol. Med., 46, 563, 10.1017/S0033291715002056 Whicher, 1998, BCR/IRMM reference material for plasma proteins (CRM470), Clin. Biochem., 31, 459, 10.1016/S0009-9120(98)00035-6 2016 Yudkin, 1999, C-reactive protein in healthy subjects. Association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?, Arterioscler. Thromb. Vasc. Biol., 19, 972, 10.1161/01.ATV.19.4.972 Zevin, 2001, Cardiovascular effects of carbon monoxide and cigarette smoking, J. Am. Coll. Cardiol., 38, 1633, 10.1016/S0735-1097(01)01616-3